Menu
Back to Journals » Clinical Ophthalmology » Volume 16
Short Report
Real-World Use of Loteprednol Etabonate 0.5%/Tobramycin 0.3% Ophthalmic Suspension for the Treatment of Ocular Surface Inflammatory Conditions
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,306 | Dovepress* | 3,192+ | 115 | 3,307 | |
| PubMed Central* | 114 | 98 | 212 | ||
| Totals | 3,306 | 213 | 3,519 | ||
| *Since 17 November 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar